Since TNF-α plays an essential role in the onset of inflammatory symptoms in autoimmune diseases, anti-TNF-α therapies targeting the interaction between TNF-α and TNF-α receptors 1 (TNFR1) and 2 (TNFR2) are attractive measures to treat patients [25]. The gene discussed is TNF; the disease is autoimmune disease.